LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis

Autor: Bo Liao MM, Shuangquan Chen MM, Yugen Li MM, Zhaohui Yang MM, Ying Yang MD, Xianzhong Deng MM, Sha Ke MM

Publikováno v: Technology in Cancer Research & Treatment, Vol 20 (2021)

Background: Long non-coding RNA bladder cancer associated transcript 1 (BLACAT1) is oncogenic in several types of cancers. However, little is known concerning its expression and function in prostate cancer. Methods: Paired prostate cancer samples wer

Externí odkaz: https://doaj.org/article/0d30d55ca0b44ce7b05bd2e232aa4cbf

MiR-331-3p Links to Drug Resistance of Pancreatic Cancer Cells by Activating WNT/β-Catenin Signal via ST7L

Autor: Ting Zhan MM, Xiaoli Chen MM, Xia Tian MM, Zheng Han MM, Meng Liu PhD, Yanli Zou MM, Shasha Huang MM, Aifang Chen MM, Xueting Cheng MM, Junsheng Deng MM, Jie Tan MM, Xiaodong Huang PhD

Publikováno v: Technology in Cancer Research & Treatment, Vol 19 (2020)

Background: Pancreatic cancer is an aggressive type of cancer with poor prognosis, short survival rate, and high mortality. Drug resistance is a major cause of treatment failure in the disease. MiR-331-3p has been reported to play an important role i

Externí odkaz: https://doaj.org/article/ef116c7c8bce45a6908ebd860674617d

Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer.

Autor: Zhang C; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Yin W; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Yuan LP; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Xiao LJ; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Yu J; Department of Cardiothoracic Surgery, The Second People's Hospital of Yi Bin City, Yi Bin, Sichuan province, China., Xiao WM; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Luo G; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Deng MM; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Liu S; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China., Lü MH; Department of Gastroenterology, The Affiliated Hospital, Southwest Medical University, Lu Zhou, Sichuan province, China. lvmuhan@swmu.edu.cn.

Publikováno v: Scientific reports [Sci Rep] 2024 Oct 25; Vol. 14 (1), pp. 25426. Date of Electronic Publication: 2024 Oct 25.

[The Effecacy and Safety of Daratumumab Based Regimens in Relapsed/Refractory Multiple Myeloma: A Single-Center Real-World Data Analysis].

Autor: Zeng HY; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, Fujian Province, China., Lin ZJ; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, Fujian Province, China., Li ZF; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, Fujian Province, China., Liu L; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, Fujian Province, China., Deng MM; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, Fujian Province, China., Xu B; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen 361003, Fujian Province, China.E-mail: xubingzhangjian@126.com.

Publikováno v: Zhongguo shi yan xue ye xue za zhi [Zhongguo Shi Yan Xue Ye Xue Za Zhi] 2024 Jun; Vol. 32 (3), pp. 763-767.

Relief of ovalbumin-induced airway remodeling by the glycyl-l-histidyl-l-lysine-Cu ²⁺ tripeptide complex via activation of SIRT1 in airway epithelial cells.

Autor: Zhang Q; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing 100029, China; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China; National Center for Respiratory Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China; Institute of Respiratory Disease, the First Hospital of China Medical University, No. 155, Nanjing Street, Heping District, 110000 Shenyang, China., Liu J; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555, Zuchongzhi Road, Pudong District, Shanghai 201203, China., Deng MM; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing 100029, China; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China; National Center for Respiratory Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China., Tong R; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing 100029, China; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China; National Center for Respiratory Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China., Hou G; Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Beijing 100029, China; National Clinical Research Center for Respiratory Diseases, Beijing 100029, China; National Center for Respiratory Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, No.2, East Yinghua Road, Chaoyang District, Beijing 100029, China. Electronic address: hougang@zryhyy.com.cn.

Publikováno v: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Aug; Vol. 164, pp. 114936. Date of Electronic Publication: 2023 May 29.